Analysis of iron homeostasis and erythroid activity in a cohort of low-risk myelodysplastic patients

被引：0
|
作者：
Messa, E. [1 ]
Maffe, C. [1 ]
Volpe, G. [1 ]
Campostrini, N. [2 ]
Gioia, D. [3 ]
Carturan, S. [1 ]
Zanone, C. [1 ]
Levis, A. [3 ]
Cilloni, D. [1 ]
Girelli, D. [2 ]
Camaschella, C. [4 ]
Saglio, G. [1 ]
机构：
[1] Univ Turin, Orbassano, Italy
[2] Univ Verona, I-37100 Verona, Italy
[3] SS Arrigo & Biagio Hosp, Alessandria, Italy
[4] S Raffaele Inst, Milan, Italy
来源：
LEUKEMIA RESEARCH | 2009年 / 33卷
关键词：
D O I：
10.1016/S0145-2126(09)70167-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：S108 / S109
页数：2
相关论文
共 50 条
  • [31] Should Patients with Low-Risk Myelodysplastic Syndrome be Treated Earlier in the Course of Their Disease?
    Eric J. Feldman
    Current Hematologic Malignancy Reports, 2011, 6 : 1 - 2
  • [32] High-dose rHuEPO for the treatment of patients with low-risk myelodysplastic syndromes
    Latagliata, R.
    Oliva, E.
    Volpicelli, P.
    Napoleone, L.
    Carmosino, I.
    Breccia, M.
    Stefanizzi, C.
    Vincelli, I.
    Alati, C.
    Vozella, F.
    Nobile, F.
    Alimena, G.
    LEUKEMIA RESEARCH, 2009, 33 : S121 - S121
  • [33] Should Patients with Low-Risk Myelodysplastic Syndrome be Treated Earlier in the Course of Their Disease?
    Feldman, Eric J.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2011, 6 (01) : 1 - 2
  • [34] Surveillance of Low-Risk Pancreatic Cysts is not Beneficial in Older Patients: A Retrospective Cohort Analysis
    Ailawadi, Shaina
    Elangovan, Abbinaya
    Maravillas, Mart Andrew
    Chak, Amitabh
    Catanzaro, Andrew
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S87 - S88
  • [35] A decision analysis to determine the appropriate treatment for low-risk myelodysplastic syndromes.
    Sekeres, MA
    Fu, AZ
    Maciejewski, JP
    Golshayan, AR
    Kalaycio, M
    Kattan, MW
    BLOOD, 2005, 106 (11) : 711A - 711A
  • [36] Leukaemia cutis in a patient with low-risk myelodysplastic syndrome
    Lin, Jinran
    Zhang, Qiao'an
    Chen, Minghua
    JOURNAL OF DERMATOLOGY, 2010, 37 : 42 - 42
  • [37] Current treatment strategies in low-risk myelodysplastic syndromes
    Giagounidis, Aristoteles A. N.
    Germing, Ulrich
    Aul, Carlo
    CANCER TREATMENT REVIEWS, 2007, 33 : S19 - S24
  • [38] Past, present and future in low-risk myelodysplastic syndrome
    Toprak, Selami Kocak
    FRONTIERS IN MEDICINE, 2022, 9
  • [39] Hepcidin and Erythroferrone in the Anemia of Low-Risk Myelodysplastic Syndromes
    Oarbeascoa, Gillen
    Redondo, Sara
    Jose Moran-Jimenez, Maria
    Domingo, Amalia
    Munoz-Linares, Cristina
    Isabel Moreno-Carralero, Maria
    Maria Bellon, Jose
    del Campo Rincon, Juan Francisco
    Luis Diez-Martin, Jose
    Font, Patricia
    BLOOD, 2018, 132
  • [40] BURDEN OF DISEASE IN LOW-RISK MYELODYSPLASTIC SYNDROMES IN SPAIN
    Valcarcel, D.
    Montoro, M. J.
    Tormo, M.
    Bargay, J.
    Moreno, E.
    Aceituno, S.
    Bellmunt, A.
    Soler, M.
    Rafel, M.
    Villarrubia, R.
    VALUE IN HEALTH, 2022, 25 (12) : S155 - S156
12345